Osaic Holdings’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $763K | Sell |
35,839
-5,593
| -13% | -$119K | ﹤0.01% | 2436 |
|
|
2025
Q1 | $637K | Buy |
41,432
+4,202
| +11% | +$64.6K | ﹤0.01% | 2645 |
|
|
2024
Q4 | $821K | Sell |
37,230
-3,839
| -9% | -$84.6K | ﹤0.01% | 2358 |
|
|
2024
Q3 | $740K | Sell |
41,069
-1,066
| -3% | -$19.2K | ﹤0.01% | 2511 |
|
|
2024
Q2 | $685K | Sell |
42,135
-10,247
| -20% | -$167K | ﹤0.01% | 2502 |
|
|
2024
Q1 | $739K | Sell |
52,382
-9,898
| -16% | -$140K | ﹤0.01% | 2603 |
|
|
2023
Q4 | $650K | Sell |
62,280
-46,191
| -43% | -$482K | ﹤0.01% | 2931 |
|
|
2023
Q3 | $1.11M | Buy |
108,471
+24,781
| +30% | +$253K | ﹤0.01% | 2549 |
|
|
2023
Q2 | $631K | Sell |
83,690
-12,206
| -13% | -$92.1K | ﹤0.01% | 2944 |
|
|
2023
Q1 | $851K | Sell |
95,896
-74,925
| -44% | -$665K | ﹤0.01% | 2631 |
|
|
2022
Q4 | $1.56M | Sell |
170,821
-18,211
| -10% | -$166K | ﹤0.01% | 1955 |
|
|
2022
Q3 | $1.53M | Buy |
189,032
+86,313
| +84% | +$697K | ﹤0.01% | 1842 |
|
|
2022
Q2 | $776K | Buy |
102,719
+5,907
| +6% | +$44.6K | ﹤0.01% | 2521 |
|
|
2022
Q1 | $1.08M | Sell |
96,812
-7,192
| -7% | -$80K | ﹤0.01% | 2503 |
|
|
2021
Q4 | $835K | Sell |
104,004
-16,000
| -13% | -$128K | ﹤0.01% | 2570 |
|
|
2021
Q3 | $1.17M | Sell |
120,004
-56,961
| -32% | -$554K | ﹤0.01% | 2204 |
|
|
2021
Q2 | $1.75M | Buy |
176,965
+34,888
| +25% | +$345K | ﹤0.01% | 1834 |
|
|
2021
Q1 | $1.64M | Buy |
142,077
+18,808
| +15% | +$217K | ﹤0.01% | 1787 |
|
|
2020
Q4 | $1.19M | Buy |
123,269
+3,799
| +3% | +$36.6K | ﹤0.01% | 1886 |
|
|
2020
Q3 | $1.09M | Buy |
119,470
+13,929
| +13% | +$127K | ﹤0.01% | 1763 |
|
|
2020
Q2 | $1.3M | Sell |
105,541
-46,196
| -30% | -$570K | ﹤0.01% | 1550 |
|
|
2020
Q1 | $1.34M | Buy |
+151,737
| New | +$1.34M | 0.01% | 1315 |
|